Efficacy of supplementation with an omega-6/omega-3 ratio of 4/1 and signaling in autism spectrum disorders
Not Applicable
Completed
- Conditions
- autism spectrum disorders
- Registration Number
- JPRN-jRCT1091220162
- Lead Sponsor
- one
- Brief Summary
Impairment in behavioral and social sequence was significantly improved at the end of 16-week treatment compared to the baseline. Plasma ceruloplasmin levels were significsantly increased at the end of treatment compared to the baseline. These findings suggest that this higher ratio of omegs-6/omega-3 supplementation improved behavioral and social ompairment via up-regulation of signasling.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Individuals who met DSM-IV criteria of autism with physicaly health
Exclusion Criteria
Individuals who have medical or mental illness except for developmental disorders. Individuals who have usually deviated fat consumption.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method